Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Prebiotics for the prevention of hyperbilirubinaemia in neonates

Esta versión no es la más reciente

ver la versión actual 13 agosto 2019

Información

DOI:
https://doi.org/10.1002/14651858.CD012731Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 20 julio 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Neonatología

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Amir Mohammad Armanian

    Correspondencia a: Division of Neonatology, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

    [email protected]

  • Shayesteh Jahanfar

    School of Health Sciences, Central Michigan University, Mount Pleasant, USA

  • Awat Feizi

    Department of Epidemiology and Biostatistics, School of Health, Endocrinology and Metabolism Research Center, Isfahan University of Medical Sciences, Isfahan, Iran

  • Mitra Molaeinezhad

    Behavioral sciences Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran

  • Nima Salehimehr

    Department of Psychology, Almahdi Mehr Higher Education Institute, Isfahan, Iran

  • Erfan Sadeghi

    Department of Epidemiology and Biostatistics, School of Health, Isfahan University of Medical Sciences, Isfahan, Iran

Contributions of authors

Dr. Armanian initiated and designed the review.

Dr. Armanian, Dr. Feizi, Dr. Sadeghi, and Dr. Salehimehr reviewed the literature and wrote the protocol.

Dr. Molaeinezhad assisted in review of the literature and in writing of the protocol.

All stages of design and writing of the protocol were performed under the guidance of Dr. Jahanfar.

Sources of support

Internal sources

  • Division of Neonatology, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Iran.

External sources

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, USA.

    Editorial support of the Cochrane Neonatal Review Group has been funded with Federal funds from the Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health, Department of Health and Human Services, USA, under Contract No. HHSN275201600005C

Declarations of interest

None to declare.

Acknowledgements

We acknowledge the opportunities provided by our institution (Isfahan University of Medical Sciences) to write this protocol.

Version history

Published

Title

Stage

Authors

Version

2019 Aug 13

Prebiotics for the prevention of hyperbilirubinaemia in neonates

Review

Amir Mohammad Armanian, Shayesteh Jahanfar, Awat Feizi, Nima Salehimehr, Mitra Molaeinezhad, Erfan Sadeghi

https://doi.org/10.1002/14651858.CD012731.pub2

2017 Jul 20

Prebiotics for the prevention of hyperbilirubinaemia in neonates

Protocol

Amir Mohammad Armanian, Shayesteh Jahanfar, Awat Feizi, Mitra Molaeinezhad, Nima Salehimehr, Erfan Sadeghi

https://doi.org/10.1002/14651858.CD012731

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.

Guidelines for phototherapy in infants at ≥ 35 weeks' gestation. (American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297.)
Figuras y tablas -
Figure 1

Guidelines for phototherapy in infants at ≥ 35 weeks' gestation. 

(American Academy of Pediatrics Subcommittee on Hyperbilirubinemia. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297.)

Ir a la figura del protocoloAbrir en una pestaña nueva

Suggested guidelines for initiating phototherapy or exchange transfusion in premature infants.(Maisels MJ, Watchko JF, Bhutani VK, et al. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. Journal of Perinatology 2012;32:660‐664.)
Figuras y tablas -
Figure 2

Suggested guidelines for initiating phototherapy or exchange transfusion in premature infants.

(Maisels MJ, Watchko JF, Bhutani VK, et al. An approach to the management of hyperbilirubinemia in the preterm infant less than 35 weeks of gestation. Journal of Perinatology 2012;32:660‐664.)

Ir a la figura del protocoloAbrir en una pestaña nueva